The alarming surge in colorectal cancer among young people may have a stomach-churning culprit.
Dr. Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, suspects exposure to a gut-dwelling bacterial toxin during childhood could pave the way for the disease decades later.
During a recent appearance before the UK Parliament, he called the theory “probably the leading explanation at the moment” for the dramatic shift in patient demographics for an illness historically associated with older adults.
His comments follow the release of a groundbreaking study last year examining colibactin, a toxin produced by certain strains of E. coli that colonize in the colon and rectum.
Researchers found that childhood exposure to the bacteria leaves behind a distinct DNA fingerprint in colon cells. These mutations were 3.3 times more common in patients with early-onset cases than in those diagnosed after age 70.
Even more concerning, colibactin-linked mutations appeared in the earliest stages of tumor development, often within the first 10 years of life.
The study also found that about 15% of APC driver mutations — among the earliest genetic changes that directly fuel cancer growth — were linked to colibactin.
“If someone acquires one of these driver mutations by the time they’re 10 years old, they could be decades ahead of schedule for developing colorectal cancer, getting it at age 40 instead of 60,” Dr. Ludmil Alexandrov, senior study author and a professor at the University of California San Diego, previously told The Post.
Established risk factors for colorectal cancer include obesity, smoking and alcohol consumption. But Smith-Byrne said these account for only about half of the cases doctors diagnose.
Testifying before the House of Commons’ science and technology committee, he said it wasn’t “plausible” that these factors alone could explain the rise in early-onset cases, per the Guardian.
Exactly how colibactin may contribute to cancer development remains unclear, but researchers are working to better understand the connection.
“If it is causing mutations, it’s causing mutations at a sensitive period earlier in life, and that can give that person’s colon or their rectum a head start on its journey towards being cancerous or developing these tumors,” Smith-Byrne said, according to the outlet.
Colibactin appears to be largely associated with people born after 1960, potentially offering a clue to the rise in cases among younger generations.
“Something has happened in the E coli bacteria … There must have been a mutation, and there is a new bacteria,” Professor Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee, according to the Guardian.
And people may have no idea they’re being exposed.
Alexandrov told The Post last year that colibactin spreads “through colonization by E. coli — typically through the gut, and often without any obvious symptoms.”
Professor Elio Riboli, a cancer epidemiologist at Imperial College London, said this colibactin is essentially found in people born after 1960.
“Something has happened in the E coli bacteria … There must have been a mutation, and there is a new bacteria,” he told the committee, according to the Guardian.
Alexandrov’s study also uncovered distinct patterns of mutations in colorectal cancer cases from countries including Argentina, Brazil, Colombia, Russia and Thailand, suggesting that local environmental exposures may influence cancer risk.
The findings could eventually pave the way for more targeted prevention strategies tailored to specific regions, researchers said.
The stakes are high. Colorectal cancer rates are climbing among young people in at least 27 countries, including in the US, where nearly 1 in 5 diagnoses now occur in young adults.
In January, the disease became the leading cause of cancer deaths among Americans under 50. Death rates in that age group have risen by 1% annually since 2005.


